Gynae BT 2017

LC 3 y:

90%

morbidity 3y ≥G3: 10% 3% OS 3 y: IGABT/ChTh: 79% NOCECA: 63%

Lindegaard et al. Acta Oncologica 2013

Made with FlippingBook - Online catalogs